A molecular basis for nonsecretory myeloma

被引:28
作者
Coriu, D
Weaver, K
Schell, M
Eulitz, M
Murphy, CL
Weiss, DT
Solomon, A
机构
[1] Univ Tennessee, Grad Sch Med, Human Immunol & Canc Program, Dept Med, Knoxville, TN 37920 USA
[2] GSF, Inst Mol Immunol, Munich, Germany
[3] Univ Med Carol Davila, Bucharest, Romania
关键词
D O I
10.1182/blood-2004-02-0477
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The biosynthesis of aberrant immunoglobulin polypeptides by monoclonal plasma cells has been implicated in the pathogenesis of nonsecretory myeloma. Our studies of a patient with this disorder indeed have demonstrated the presence of abnormal kappa light chains that resulted from a frameshift mutation in nucleotides encoding the constant region of the molecule. As a consequence of a 2-base deletion in codon 187 and loss of the normal stop codon, this portion of the kappa chain was composed of 128 amino acids (rather than the expected 106), with a completely anomalous sequence after position 187 that included absence of the cysteines required for intrachain and interchain disulfide bonds. The unusual primary structure of this component was confirmed by mass spectrometric and amino acid sequence analyses of cytoplasmic protein extracts. Our studies provide the first evidence that human nonsecretory myeloma may result from an alteration in the light-chain constant region.
引用
收藏
页码:829 / 831
页数:3
相关论文
共 21 条
[1]   PRODUCTION AND IMMUNODIAGNOSTIC APPLICATIONS OF ANTIHUMAN LIGHT-CHAIN MONOCLONAL-ANTIBODIES [J].
ABE, M ;
GOTO, T ;
KENNEL, SJ ;
WOLFENBARGER, D ;
MACY, SD ;
WEISS, DT ;
SOLOMON, A .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 100 (01) :67-74
[2]  
Abe M, 1998, CLIN EXP IMMUNOL, V111, P457
[3]   The human antibody repertoire: Heavy and light chain variable region gene usage in six alloantibodies specific for human HLA class I and class II alloantigens [J].
Andris, JS ;
Abraham, SR ;
Pascual, V ;
Pistillo, MP ;
Mantero, S ;
Ferrara, GB ;
Capra, JD .
MOLECULAR IMMUNOLOGY, 1995, 32 (14-15) :1105-1122
[4]  
[Anonymous], 1988, Antibodies: A Laboratory Manual
[5]   Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia [J].
Bladé, J ;
Kyle, RA .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (06) :1259-+
[6]   NONSECRETORY MULTIPLE-MYELOMA - PRESENTING FINDINGS, CLINICAL COURSE AND PROGNOSIS [J].
CAVO, M ;
GALIENI, P ;
GOBBI, M ;
BALDRATI, L ;
LEARDINI, L ;
BACCARANI, M ;
TURA, S .
ACTA HAEMATOLOGICA, 1985, 74 (01) :27-30
[7]   EXON SKIPPING WITHOUT SPLICE-SITE MUTATION ACCOUNTING FOR ABNORMAL IMMUNOGLOBULIN-CHAINS IN NONSECRETORY HUMAN MYELOMA [J].
COGNE, M ;
GUGLIELMI, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (06) :1289-1293
[8]  
Davis DP, 1999, J IMMUNOL, V163, P3842
[9]   Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma [J].
Drayson, M ;
Tang, LX ;
Drew, R ;
Mead, GP ;
Carr-Smith, H ;
Bradwell, AR .
BLOOD, 2001, 97 (09) :2900-2902
[10]   A SINGLE AMINO-ACID SUBSTITUTION IN THE VARIABLE REGION OF THE LIGHT CHAIN SPECIFICALLY BLOCKS IMMUNOGLOBULIN SECRETION [J].
DUL, JL ;
ARGON, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (20) :8135-8139